| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 09/06/2000 | EP1032393A1 QUINOLINE-CONTAINING $g(a)-KETOAMIDE CYSTEINE AND SERINE PROTEASE INHIBITORS |
| 09/06/2000 | EP1032392A1 Antihistamine/decongestant regimens for treating rhinitis |
| 09/06/2000 | EP1032391A1 Spheroids containing tiagabine, preparation process and pharmaceutical compositions |
| 09/06/2000 | EP1032390A1 Anaesthetic formulation |
| 09/06/2000 | EP1032389A1 CHRONIC, BOLUS ADMINISTRATION OF D-threo METHYLPHENIDATE |
| 09/06/2000 | EP1032388A1 Novel metal complexes |
| 09/06/2000 | EP1032387A1 Novel metal complexes |
| 09/06/2000 | EP1032386A1 Use of oxazolidinone derivatitives for treating psoriasis, arthritis and reducing the toxicity of cancer chemotherapy |
| 09/06/2000 | EP1032385A1 Use of substituted diphenyl indanone, indane and indole compounds for the treatment or prevention of sickle cell disease, inflammatory diseases characterized by abnormal cellproliferation, diarrhe and scours |
| 09/06/2000 | EP1032384A1 Carbapenem antibacterial compounds, compositions and methods of treatment |
| 09/06/2000 | EP1032383A1 Antibacterial carbapenems, compositions and methods of treatmemt |
| 09/06/2000 | EP1032381A1 Naringin and naringenin as inhibitor of acyl coa-cholesterol-o-acyltransferase, inhibitor of macrophage-lipid complex accumulation on the arterial wall and preventive or treating agent for hepatic diseases |
| 09/06/2000 | EP1032380A1 Use of delta 5-androstene-3 beta-ol-7,17-dione in the treatment of lupus erythematosus |
| 09/06/2000 | EP1032379A1 Composition with azelaic acid |
| 09/06/2000 | EP1032378A1 Use of a mixture of a diol and an alpha-hydroxy acid for the treatment of hyperkeratotic skin diseases |
| 09/06/2000 | EP1032377A1 Substituted 2-aminoacetamides and the use thereof |
| 09/06/2000 | EP1032376A1 Use of sulphinyl benzhydryl derivatives for treating drug-induced sleepiness |
| 09/06/2000 | EP1032374A1 Spheroids, preparation method and pharmaceutical compositions |
| 09/06/2000 | EP1032373A1 Drug delivery systems utilizing liquid crystal structures |
| 09/06/2000 | EP1032371A1 Polyethylene glycol matrix pellets for greasy, oily or sticky drug substances |
| 09/06/2000 | EP1032370A1 Porous hydroxyapatite particles as carriers for drug substances |
| 09/06/2000 | EP1032368A1 Iontophoretic devices comprising piperidin derivatives |
| 09/06/2000 | EP1032364A1 Topical compositions containing sialyl sugars and their derivatives |
| 09/06/2000 | EP1032304A1 Reagent for tumor therapy and/or imaging |
| 09/06/2000 | EP1032266A1 Use of delta5-androstene-3beta-ol-7,17-dione in the treatment of arthritis |
| 09/06/2000 | EP1032265A1 New psoralens for pathogen inactivation |
| 09/06/2000 | EP1032264A1 Method of enhancing the antimicrobial properties of antibacterial antibiotics |
| 09/06/2000 | EP1032263A1 Surfactant-based antimicrobial compositions and methods for using same |
| 09/06/2000 | EP0912172B1 Combination of cis-4-hydroxy-l-proline and n-methyl-cis-4-hydroxy-l-proline for use as a therapeutic agent, in particular in cancer treatment |
| 09/06/2000 | EP0901379B1 Type-2 chemokine binding proteins and methods of use therefor |
| 09/06/2000 | EP0882066B1 Peptide derivatives |
| 09/06/2000 | EP0817612B1 Transparent rapid-release preparations of non-steroid analgesics |
| 09/06/2000 | EP0792149B1 Oral compositions containing ondansetron |
| 09/06/2000 | EP0770089B1 Growth differentiation factor-12 |
| 09/06/2000 | EP0719145B1 Nitric oxide donor composition for treatment of anal disorders |
| 09/06/2000 | EP0711134B1 Medicinal for protection from neurological damage |
| 09/06/2000 | EP0702672B1 Substituted quinoline derivatives and their use as inhibitors of gastric acid secretion |
| 09/06/2000 | EP0697864B1 Use of ferrioxamine b in the treatment os septic shock |
| 09/06/2000 | EP0665844B1 Substituted benzylaminoquinuclidines as substance p antagonists |
| 09/06/2000 | EP0661974B1 Methods and compositions for treating infection using optically pure (r)-lomefloxacin |
| 09/06/2000 | EP0642345B1 Halichondrins and related compounds |
| 09/06/2000 | EP0593766B1 Pyridonecarboxylic acid derivative |
| 09/06/2000 | EP0590015B1 Tissue treatment composition comprising fibrin or fibrinogen and biodegradable and biocompatible polymer |
| 09/06/2000 | EP0568608B1 Fungal oil containing arachidonic acid, method for its preparation and composition containing said oil |
| 09/06/2000 | CN1265741A Method and compositions for overcoming resistance to biologic and chemotherapy |
| 09/06/2000 | CN1265675A Benzyl compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| 09/06/2000 | CN1265669A Compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| 09/06/2000 | CN1265665A Benzimidazole derivatives |
| 09/06/2000 | CN1265662A Process for selective preparation of z-isomers of 3-(2-substituted vinyl) cephalsporins |
| 09/06/2000 | CN1265660A 2-(4-aryl or heteroaryl-piperazin-1-ylmethyl)-1H-indole derivatives |
| 09/06/2000 | CN1265659A Substituted cyclobutylamine derivatives |
| 09/06/2000 | CN1265658A 5-naphthalen-1-yl-1,3-dioxane derivatives, preparation and therapeutic application |
| 09/06/2000 | CN1265657A Carbamyloxy compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| 09/06/2000 | CN1265656A O-substituted hydroxycumaranone derivatives as anttumor and antimetastatic agents |
| 09/06/2000 | CN1265654A 1-(N-phenylaminoalkyl)-piperazine derivatives substituted at position 2 of phenyl ring |
| 09/06/2000 | CN1265652A 2-acrylaminopropanamines as tachykinin receptor antagonists |
| 09/06/2000 | CN1265651A Novel tircyclic compounds having saturated rings and medicinalcompositions containing the same |
| 09/06/2000 | CN1265650A Special 3-azabicyclo [3,1,0] hexanes, method for producing and modifying the same, and their use |
| 09/06/2000 | CN1265649A Indole derivatives as MCP-1 receptor antagonists |
| 09/06/2000 | CN1265648A Conjugaes of dithiocarbamates with pharmacologically active agents and uses therefor |
| 09/06/2000 | CN1265647A Acrylic metalloprotease inhibitor |
| 09/06/2000 | CN1265646A Aryloxyarylsulfonylamino hydroxamic acid derivatives |
| 09/06/2000 | CN1265645A Urokinase inhibitors |
| 09/06/2000 | CN1265643A Anthranilic acid analogs |
| 09/06/2000 | CN1265634A Improved method for preparing low-concentration polyaluminosilicate microgels |
| 09/06/2000 | CN1265598A Method for treating thrombotic disorders |
| 09/06/2000 | CN1265596A Isoflavone-containing compositions |
| 09/06/2000 | CN1265595A Pharmaceutical composition containing vitamin D and calcium, their preparation and therapeutic use |
| 09/06/2000 | CN1265594A Method for treating mastitis in domestic animal using rifamycin derivative |
| 09/06/2000 | CN1265593A Novel process for manufacturing paroxetine solid dispersions |
| 09/06/2000 | CN1265592A A pharmaceutical composition active in reducing production of MCP-1 protein |
| 09/06/2000 | CN1265591A Coumpound |
| 09/06/2000 | CN1265590A Substituted alkanohydroxamic acid and method of reducing TNF 'alpha' levels |
| 09/06/2000 | CN1265589A Enantiomers of 4-[[(cyanoimino)-[(1,2,2-trimethylpropyl) amino] methyl] amino] benzonitrile |
| 09/06/2000 | CN1265588A Protecting and survival promoting agent for central nervous cell |
| 09/06/2000 | CN1265587A Fast-acting analgesic |
| 09/06/2000 | CN1265586A Use of a specific antagonist of 5HTz recepotors for preparing medicine useful for treating sleep-disordered breathing |
| 09/06/2000 | CN1265585A (Imidazol-5-yl) methyl-2-quinolinone derivatives as inhibitors of smooth muscle cell proliferation |
| 09/06/2000 | CN1265584A Ascorbic acid-based formulation with improved colour stability |
| 09/06/2000 | CN1265583A Aqueous aerosol preparations containing biologically active macromolecules and method for producing the corresponding aerosols |
| 09/06/2000 | CN1265560A Composition and method for curing diabetes |
| 09/06/2000 | CN1265393A Process for preparing N-(amino-4,6-dihalopyrimidine) formamide |
| 09/06/2000 | CN1265320A Natural herbal medicine composition with the functions of stopping itching, disinfection and antiphlogosis and its preparation |
| 09/06/2000 | CN1265319A Medicine for dredging the meridian passage and softening mass and its preparation |
| 09/06/2000 | CN1265315A Medicine mixture with rhubarb and other herbal medicine material |
| 09/06/2000 | CN1265308A Application of magnesium fructose-1,6-diphosphate in medicine |
| 09/06/2000 | CN1056151C 17-deoxycorticosteroid-21-(O)-carboxylic esters, process for their preparation and pharmaceuticals containing these compounds |
| 09/06/2000 | CN1056145C Prepn. of 1,3-oxathiolane nucleoside analogue medicine composition |
| 09/06/2000 | CN1056144C New use of 6-heterocyclic-4-amino-3,4,5-tetrahydrobenz (CD) indoles compound |
| 09/06/2000 | CN1056143C Piperidine derivatives and its use |
| 09/06/2000 | CN1056142C Anti-cancer medicine inula helianthus-aquatica lactone |
| 09/06/2000 | CN1056141C 哌嗪衍生物 Piperazine derivatives |
| 09/06/2000 | CN1056140C Biphenyl derivatives, their preparation and theirt use for treatment of hypertension and cardiac disease |
| 09/06/2000 | CN1056085C Tocols as adjuvant in vaccine |
| 09/06/2000 | CN1056082C Anticancer drug |
| 09/06/2000 | CN1056066C Health medicine able to help somebody to sleep |
| 09/06/2000 | CN1056061C Medicine for treating self-biting disease for fox and preparing process thereof |
| 09/06/2000 | CN1056058C Prep. of pharmaceutical formulation |
| 09/06/2000 | CN1056057C Pharmaceutical compositions permitting the prolonged release of trimetazidine after oral administraion |
| 09/05/2000 | US6114568 Process for alkylating hindered sulfonamides useful in the production of matrix metalloproteinase inhibitors |